))
Drug Development & Patient Advisory Boards - Cholangiocarcinoma Series
Manage episode 316260672 series 2861129
Tammy Flynn, Tammy Flynn: podcaster, and Special needs advocate a द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री Tammy Flynn, Tammy Flynn: podcaster, and Special needs advocate a या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।
As we continue our Cholangiocarcinoma Series I am excited to welcome, Peter Langmuir, M.D., Group Vice President, Oncology Targeted Therapies, Incyte.
Peter Langmuir, M.D. is Group Vice President of Oncology Targeted Therapeutics at Incyte.
Dr. Langmuir earned his medical degree at the Yale University School of Medicine and trained in pediatrics and pediatric hematology-oncology at The Children’s Hospital of Philadelphia.
He has worked in the pharmaceutical and biotech industry for the past 18 years, focusing primarily on the clinical development of targeted therapies for both solid tumors and hematologic malignancies.
Listen in as Peter shares about the collaboration between Incyte and the Cholangiocarcinoma Foundation with drug development & patient advisory boards.
Learn More About Cholangiocarcinoma At: https://cholangiocarcinoma.org/
Visit http://www.onairadvocate.com for information on all of our products, services & resources.
#bileductcancer
100 एपिसोडस
साझा करें
